| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 760.5 | 666.2 | 678.7 |
| Other income | 12.7 | 15.2 | 0.1 |
| Total income | 773.2 | 681.4 | 678.8 |
| Profit before exceptional items & tax | 158.5 | 113.4 | 125.1 |
| Profit before tax | 158.5 | 113.4 | 125.1 |
| Net profit | 117.5 | 82.8 | 90.2 |
| Operating margin | 20.5% | 16.6% | 18.4% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +30.30% |
|---|---|
| Net profit, quarter on quarter | +41.90% |
| Revenue, year on year | +12.10% |
| Operating profit, year on year | +16.60% |
| Operating profit, quarter on quarter | +48.50% |
BSE results filing, NSE: PRIVISCL. Figures extracted from the filing.
Privi Speciality Chemicals Ltd: key numbers
- Share price
- ₹3,500.00
- Market cap
- ₹13,672 Cr
- Revenue (annual)
- ₹2,564 Cr
- Net profit (annual)
- ₹327.5 Cr
- P/E (TTM)
- 39.1×Sector 34.1×
- Promoter holding
- 60.60%+0.00% QoQ
- FII holding
- 2.78%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Privi Speciality Chemicals Ltd
All →Privi Speciality Chemicals Dividend
Privi Speciality Chemicals declared an interim dividend of Rs 5 per equity share for FY 2026-27 at its 29 October 2026 board meeting. Record date is 04 November 2026 and payment by 25 November 2026.
Privi Speciality Chemicals Acquisition
Privi Speciality Chemicals' NCLT-convened equity shareholder meeting approved the Scheme of Amalgamation of Privi Fine Sciences and Privi Biotechnologies into the company. The special resolution passed with requisite majority, subject to scrutinizer report.
Privi Speciality Chemicals Board Meeting Date
Privi Speciality Chemicals intimated its board meeting is scheduled for October 29, 2026, to consider Q1/H1 results and an interim dividend. Items are proposed only and not yet decided.
Privi Speciality Chemicals Other Announcement
Privi Speciality Chemicals Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.
Privi Speciality Chemicals Acquisition
Privi Speciality Chemicals filed NCLT notice for an Oct 27, 2026 shareholders meeting on the amalgamation of Privi Fine Sciences and Privi Biotechnologies into it. No merger consideration value is stated.
Privi Speciality Chemicals Capital Structure Change
SBI Mutual Fund sold 18,400 shares of Privi Speciality Chemicals Ltd via open market, reducing its stake from 7.3905% to 7.3434%.